Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Polygenic susceptibility to breast cancer and implications for prevention

Abstract

The knowledge of human genetic variation that will come from the human genome sequence makes feasible a polygenic approach to disease prevention, in which it will be possible to identify individuals as susceptible by their genotype profile and to prevent disease by targeting interventions to those at risk. There is doubt, however, regarding the magnitude of these genetic effects and thus the potential to apply them to either individuals or populations. We have therefore examined the potential for prediction of risk based on common genetic variation using data from a population-based series of individuals with breast cancer. The data are compatible with a log-normal distribution of genetic risk in the population that is sufficiently wide to provide useful discrimination of high- and low-risk groups. Assuming all of the susceptibility genes could be identified, the half of the population at highest risk would account for 88% of all affected individuals. By contrast, if currently identified risk factors for breast cancer were used to stratify the population, the half of the population at highest risk would account for only 62% of all cases. These results suggest that the construction and use of genetic-risk profiles may provide significant improvements in the efficacy of population-based programs of intervention for cancers and other diseases.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Distribution of breast cancer risk in the population and in individual cases.
Figure 2: Proportion of population above a specified absolute risk of breast cancer and proportion of cases occurring in that fraction of the population.
Figure 3: Proportion of cases accounted for by a given proportion of the population above a specified risk according to the standard deviation of underlying risk distribution.

Similar content being viewed by others

References

  1. Bell, J. The new genetics in clinical practice. Br. Med. J. 316, 618–620 (1998).

    Article  CAS  Google Scholar 

  2. Beaudet, A.L. 1998 ASHG presidential address. Making genomic medicine a reality. Am. J. Hum. Genet. 64, 1–13 (1999).

    Article  CAS  Google Scholar 

  3. Friend, S.H. How DNA microarrays and expression profiling will affect clinical practice. Br. Med. J. 319, 1306–1307 (1999).

    Article  CAS  Google Scholar 

  4. Holtzman, N.A. & Marteau, T.M. Will genetics revolutionize medicine? N. Engl. J. Med. 343, 141–144 (2000).

    Article  CAS  Google Scholar 

  5. Vineis, P., Schulte, P. & McMichael, A.J. Misconceptions about the use of genetic tests in populations. Lancet 357, 709–712 (2001).

    Article  CAS  Google Scholar 

  6. Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85 (2000).

    Article  CAS  Google Scholar 

  7. Peto, J. & Mack, T.M. High constant incidence in twins and other relatives of women with breast cancer. Nature Genet. 26, 411–414 (2000).

    Article  CAS  Google Scholar 

  8. Easton, D.F. How many more breast cancer predisposition genes are there? Breast Cancer Res. 1, 14–17 (1999).

    Article  CAS  Google Scholar 

  9. Anglian Breast Cancer Study Group. Prevalence and penetrance of BRCA1 and BRCA2 in a population based series of breast cancer cases. Br. J. Cancer 83, 1301–1308 (2000).

  10. Antoniou, A.C. et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population based study. Genet. Epidemiol. 21, 1–18 (2001).

    Article  CAS  Google Scholar 

  11. Antoniou, A.C. et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br. J. Cancer in press (2001).

  12. Pharoah, P.D.P. & Mackay, J. Absolute risk of breast cancer in women at increased risk: a more useful clinical measure than relative risk? The Breast 7, 255–259 (1998).

    Article  Google Scholar 

  13. Vaittinen, P. & Hemminki, K. Risk factors and age-incidence relationships for contralateral breast cancer. Int. J. Cancer 88, 998–1002 (2000).

    Article  CAS  Google Scholar 

  14. Risch, N. The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer. Epidemiol. Biomarkers Prev. 10, 733–741 (2001).

    CAS  PubMed  Google Scholar 

  15. Kelsey, J.L., Gammon, M.D. & John, E.M. Reproductive factors and breast cancer. Epidemiol. Rev. 15, 36–47 (1993).

    Article  CAS  Google Scholar 

  16. Cui, J. et al. After BRCA1 and BRCA2—what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am. J. Hum. Genet. 68, 420–431 (2001).

    Article  CAS  Google Scholar 

  17. Pharoah, P.D.P., Day, N.E., Duffy, S., Easton, D.F. & Ponder, B.A.J. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int. J. Cancer 71, 800–809 (1997).

    Article  CAS  Google Scholar 

  18. Rose, G. Sick individuals and sick populations. Int. J. Epidemiol. 14, 32–38 (1985).

    Article  CAS  Google Scholar 

  19. Dunning, A.M. et al. A systematic review of genetic polymorphisms and breast cancer risk. Cancer. Epidemiol. Biomarkers Prev. 8, 843–854 (1999).

    CAS  PubMed  Google Scholar 

  20. Kerlikowske, K., Grady, D., Rubin, S.M., Sandrock, C. & Ernster, V.L. Efficacy of screening mammography. A meta-analysis. J.A.M.A. 273, 149–154 (1995).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

P.P. is a Senior Clinical Research Fellow, D.F.E. is a Principal Fellow and B.A.J.P. is a Gibb Fellow of Cancer Research UK. The Public Health Genetics Unit is funded by the Eastern Regional Office of the National Health Service Executive. Research in the Strangeways Laboratories is supported by a grant from the National Lottery Board and by program grants from Cancer Research UK and the Medical Research Council. We thank H. Burton, C. Brayne, M. Austin and N. Day for their helpful comments on early drafts of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul D.P. Pharoah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pharoah, P., Antoniou, A., Bobrow, M. et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31, 33–36 (2002). https://doi.org/10.1038/ng853

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng853

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing